2015
DOI: 10.1586/14737175.2015.1068120
|View full text |Cite
|
Sign up to set email alerts
|

Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer’s disease: a meta-analysis

Abstract: Rivastigmine treatment shows a positive result of improving the condition of patients with mild-to-severe AD. Patch administration shows a stronger effect on decreasing ADAS-Cog score compared to capsule administration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Furthermore, the Hospital Anxiety and Depression Scale (HADS > 10) was used to exclude individuals with depression and anxiety. The MMSE score was used to grade the severity of AD (23,24). MMSE scores of 0-20 and 21-26 indicate moderate to severe AD and mild AD, respectively.…”
Section: Participantsmentioning
confidence: 99%
“…Furthermore, the Hospital Anxiety and Depression Scale (HADS > 10) was used to exclude individuals with depression and anxiety. The MMSE score was used to grade the severity of AD (23,24). MMSE scores of 0-20 and 21-26 indicate moderate to severe AD and mild AD, respectively.…”
Section: Participantsmentioning
confidence: 99%